Incidental gallbladder cancer: can we improve survival?
نویسندگان
چکیده
منابع مشابه
Incidental Gallbladder Cancer
Gallbladder cancer (GBC) is a rare but fatal disease with an incidence of less than 5000 new cases per year in the United States. Less than 20% of GBC cases are diagnosed preoperatively. The remaining cases are diagnosed either after laparoscopic cholecystectomy or intraoperatively. GBC is discovered incidentally during histopathology following 0.25–3.0% of laparoscopic cholecystectomies; howev...
متن کاملIncidental gallbladder cancer: analysis of surgical findings and survival.
BACKGROUND AND OBJECTIVES Incidental gallbladder cancer (IGBCA) has risen worldwide and its prognosis depends on complete radical cholecystectomy (CRC). This study evaluated surgical findings during re-operation and survival of patients with IGBCA. METHODS Demographics, surgical treatment, staging, and survival data for all IGBCA patients who underwent surgery at Instituto Oncológico Fundació...
متن کاملIncidental gallbladder cancer after routine cholecystectomy: when should we suspect it preoperatively and what are predictors of patient survival?
PURPOSE In about 1% of cases, incidental gallbladder cancers (iGBC) are found after routine cholecystectomy. The aim of this study is to compare clinical features of iGBC with benign GB disease and to evaluate factors affecting recurrence and survival. METHODS Between January 1998 and March 2014, 4,629 patients received cholecystectomy and 73 iGBC patients (1.6%) were identified. We compared ...
متن کاملCan we improve estimates of juvenile dispersal distance and survival?
Estimates of distributions of natal dispersal distances and juvenile recruitment rates in open populations are strongly influenced by the extent and shape of the areas sampled. Techniques to improve biased dispersal and survival estimates include area-ratio methods based on weighting observations by sampling effort, the extent and shape of the area sampled, and the amount and distribution of pr...
متن کاملCancer Vaccines in Ovarian Cancer: How Can We Improve?
Epithelial ovarian cancer (EOC) is one important cause of gynecologic cancer-related death. Currently, the mainstay of ovarian cancer treatment consists of cytoreductive surgery and platinum-based chemotherapy (introduced 30 years ago) but, as the disease is usually diagnosed at an advanced stage, its prognosis remains very poor. Clearly, there is a critical need for new treatment options, and ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2019
ISSN: 0923-7534
DOI: 10.1093/annonc/mdz155.070